Jenna McAfee
Biographic Data
| ID | 7181501 |
|---|---|
| NAME | Jenna McAfee |
| GIVEN NAMES | Jenna |
| FAMILY NAME | McAfee |
| SIGNATURE | MCAFEE J |
| AFFILIATIONS | University of Michigan |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Direct and indirect effects of cannabis risk perceptions on cannabis use frequency
Among emerging adults who consume cannabis regularly, findings suggest that a greater perceived risk of cannabis-related harm is associated with decreased cannabis use frequency via increased use of cannabis PBS. Although future analyses evaluating causal mechanisms are needed, these findings have clinical implications for harm reduction interventions focused on cannabis use
Applying Lessons From Cannabis to the Psychedelic Highway
In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers. Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of psychedelics for psychiatric conditions 2,3 and the e…
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia
Fibromyalgia (FM) is a difficult to treat chronic pain condition for which there is strong interest in alternative treatments. There is growing interest in the potential of psychedelic substances (e.g., psilocybin) in conjunction with psychotherapy to treat chronic pain. Via a cross-sectional, anonymous, online survey, we aimed to characterize knowledge, perceptions, and past use of serotonergic ("classic") and non-serotonergic psychedelics among…
Medication and substance use increases among people using cannabis medically during the Covid-19 pandemic
No prominent works on this page.
Medication and substance use increases among people using cannabis medically during the Covid-19 pandemic
Applying Lessons From Cannabis to the Psychedelic Highway
In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers. Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of psychedelics for psychiatric conditions 2,3 and the e…
Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia
Fibromyalgia (FM) is a difficult to treat chronic pain condition for which there is strong interest in alternative treatments. There is growing interest in the potential of psychedelic substances (e.g., psilocybin) in conjunction with psychotherapy to treat chronic pain. Via a cross-sectional, anonymous, online survey, we aimed to characterize knowledge, perceptions, and past use of serotonergic ("classic") and non-serotonergic psychedelics among…
Direct and indirect effects of cannabis risk perceptions on cannabis use frequency
Among emerging adults who consume cannabis regularly, findings suggest that a greater perceived risk of cannabis-related harm is associated with decreased cannabis use frequency via increased use of cannabis PBS. Although future analyses evaluating causal mechanisms are needed, these findings have clinical implications for harm reduction interventions focused on cannabis use
Psychiatry (4 works) · Cannabis (3 works) · Medicine (3 works) · Psychology (3 works) · Cannabis and Cannabinoid Research (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Environmental health (2 works) · Perception (2 works) · Population (2 works)